Literature DB >> 3816155

Hepatic 3 alpha-dehydrogenation and 7 alpha-hydroxylation of deoxycholic acid in the guinea-pig.

A Cantafora, D Alvaro, A F Attili, A Di Biase, M Anza, A Mantovani, M Angelico.   

Abstract

The metabolic fate of exogenous deoxycholate administered either intraperitoneally or intragastrically to male Hartley guinea-pigs was investigated. Two animals received a constant infusion of [24-14C]deoxycholate through an intraperitoneal catheter for 2 hr. Bile was quantitatively collected in 30 min samples during infusion and for 2 additional hours. Each bile sample was analyzed for composition and radioactivity. Five animals received for 15 days, through an intragastric catheter, 35 mg/kg/day of deoxycholate. The biliary bile acid composition was compared with that of a sham-operated control group. The studies with both animal models indicated that guinea-pigs, as the only species so far known, extensively oxidize deoxycholate to form 3-oxo,12 alpha-hydroxy-cholanic acid, which is secreted in bile mostly conjugated with glycine. In addition a small fraction (approx. 7%) of the administered deoxycholate is 7 alpha hydroxylated to form cholic acid. The metabolites being more hydrophilic than administered deoxycholate, it is suggested that guinea-pig liver counteracts the adverse increase in bile acids detergency, which follows deoxycholate administration, by converting most of the latter into less detergent compounds.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816155     DOI: 10.1016/0305-0491(86)90179-3

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  2 in total

1.  Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.

Authors:  Youcai Zhang; Curtis D Klaassen
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

Review 2.  Bile salts of vertebrates: structural variation and possible evolutionary significance.

Authors:  Alan F Hofmann; Lee R Hagey; Matthew D Krasowski
Journal:  J Lipid Res       Date:  2009-07-28       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.